Medical device company Procyrion Closes $57.7 Million Series E Financing Round
Briefly

from Silicon Valley Journals1 year ago
"The funding will enable Procyrion to advance its Aortix technology, a miniaturized circulatory support device designed for the treatment of heart failure patients.,"
Silicon Valley Journalshttps://siliconvalleyjournals.com/medical-device-company-procyrion-closes-57-7-million-series-e-financing-round/
"Aortix can make a meaningful impact on the lives of heart failure patients, and this funding will help us bring this technology to more patients in need," said Benjamin A. Hertzog, Chief Executive Officer of Procyrion.
Silicon Valley Journalshttps://siliconvalleyjournals.com/medical-device-company-procyrion-closes-57-7-million-series-e-financing-round/
Read at Silicon Valley Journals
[
|
]